ArticleClinical pharmacology in drug development2026
Phase 1 Study of Paltusotine, a Novel Oral Once‑Daily, Nonpeptide Selective Somatostatin Receptor 2 Agonist, in Healthy Japanese Adults.
Fumio Otsuka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.